N-Sulfonated-N-Heterocycles

N-Sulfonated-N-Heterocycles covers the synthesis, chemistry and biological applications of these compounds, focusing on pioneering synthetic approaches, mechanistic insights and their limitations, as well as recent advances in this field. The synthesis of some of N-sulfonated N-heterocycles and their transformation to other useful cyclic and acyclic compounds are discussed, as well as their uses as useful intermediates in the preparation of polymeric and medicinal materials. This book includes detailed methods and protocols, and the focus on applications makes this resource an essential guide for all researchers in the area of organic, medicinal and polymeric synthetic study. Reviews the use of N-sulfonated N-heterocycles as important precursors for the synthesis of biologically active compounds Includes information on synthetically useful transformations of N-sulfonated N-heterocycles Covers a wide synthetic methods used for an important branch of heterocycles and their biological evaluation in detail Features over 500 schemes to illustrate different synthetic pathways and reactions of N-sulfonated N-heterocycles

Auteur

Galal H. Elgemeie is the author of over 270 scientific international papers on heterocyclic chemistry and medicinal chemistry. His research interests include the development and mechanistic understanding of organic reactions and their application to the synthesis of antimetabolic agents. He was an international elected member of the Scientific Board of the International Basic Sciences Programme (IBSP), UNESCO, in Paris, France. He was a postdoctoral fellow of the Alexander von Humboldt Foundation in Germany, the Fulbright in USA, the British Council in England, and then the German Research Foundation (DFG) in Germany. He supervised several cooperation projects with the European Community under the TEMUPS programme, Prof. Elgemeie was nominated as one of the leading scientists of the COMSTECH in the year 2009 Report. Prof. Elgemeie's research activities have received many awards including The African Union Scientific Award "Continental Scientific Award" in Science and Technology, The ISESCO Scientific Award and The Egypt State Honor Award "NILE", among many others.Rasha Azzam, Professor of Organic Chemistry, is an active researcher in the area of organic chemistry (from drug design and synthesis to drug delivery). She obtained her PhD from Catholic University of Leuven, Belgium, under a research fellowship and supervision of Distinguished Research Prof. Georges Hoornaert and Prof. Frans Compernolle. After her PhD, she assumed her position as an Assistance Professor at Helwan University. During her tenure at Helwan University, she was appointed as assistant/associate professor at three different universities before returning back to her position at Helwan University. Azzam was awarded the Outstanding Faculty Member Award in 2007 and the Silver Medal from ASRT in 2018. She has published more than forty international peer-reviewed publications in addition to several international conference presentations. She has supervised more that fifteen graduate-level theses and secured funding for over seven major educational grants.Wafaa Zaghary is a Professor of Pharmaceutical Chemistry, the head and founder of Pharmaceutical Chemistry Department, Faculty of Pharmacy, Helwan University. She is one of the expert Egyptian medicinal chemists especially in the design and synthesis of new chemical scaffolds targeting cancer. In addition, she had been involved in the nano-nuclear pharmacy research and radiopharmaceutical fields. Prof. Zaghary with her group had discovered novel tumor imaging agent with nanographene oxide sheets (2022), DNA gyrase & topoisomerase IV inhibitors (2021), Novel thienopyrimidine analogues as potent mGR-1 inhibitors with anticancer activity (2021), coumarin-based lead compound with CDK-4 inhibitory and anticancer activity (2021), Nano-selenium platforms as protective agents for hepatocellular carcinoma (2021), new aldose reductase inhibitors with anticancer action (2019), potential EGFR inhibitors (indazole, quinazoline, and quinolones) (2019). She has been involved in many research projects (Helwan University), (King Saud University) and (National Research Centre in Egypt). In 2018, She received the ''outstanding research award'' Helwan University.